vs
Side-by-side financial comparison of RHYTHM PHARMACEUTICALS, INC. (RYTM) and Waterstone Financial, Inc. (WSBF). Click either name above to swap in a different company.
RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($57.3M vs $37.2M, roughly 1.5× Waterstone Financial, Inc.). On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 16.7%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 7.1%).
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
Waterstone Financial, Inc. is a U.S. bank holding company headquartered in Wisconsin. It offers retail and commercial banking services, residential mortgages, and wealth management solutions, primarily serving consumers and small to medium-sized businesses across the U.S. Midwest region.
RYTM vs WSBF — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $57.3M | $37.2M |
| Net Profit | $-47.5M | — |
| Gross Margin | 91.6% | — |
| Operating Margin | -82.2% | 27.0% |
| Net Margin | -83.0% | — |
| Revenue YoY | 36.9% | 16.7% |
| Net Profit YoY | -9.6% | — |
| EPS (diluted) | $-0.73 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $57.3M | $37.2M | ||
| Q3 25 | $51.3M | $37.0M | ||
| Q2 25 | $48.5M | $38.0M | ||
| Q1 25 | $32.7M | $29.7M | ||
| Q4 24 | $41.8M | $31.8M | ||
| Q3 24 | $33.3M | $34.1M | ||
| Q2 24 | $29.1M | $37.2M | ||
| Q1 24 | $26.0M | $32.4M |
| Q4 25 | $-47.5M | — | ||
| Q3 25 | $-52.9M | $7.9M | ||
| Q2 25 | $-46.6M | $7.7M | ||
| Q1 25 | $-49.5M | $3.0M | ||
| Q4 24 | $-43.3M | — | ||
| Q3 24 | $-43.6M | $4.7M | ||
| Q2 24 | $-32.3M | $5.7M | ||
| Q1 24 | $-141.4M | $3.0M |
| Q4 25 | 91.6% | — | ||
| Q3 25 | 89.3% | — | ||
| Q2 25 | 88.6% | — | ||
| Q1 25 | 88.8% | — | ||
| Q4 24 | 90.9% | — | ||
| Q3 24 | 88.5% | — | ||
| Q2 24 | 89.9% | — | ||
| Q1 24 | 89.2% | — |
| Q4 25 | -82.2% | 27.0% | ||
| Q3 25 | -102.6% | 26.6% | ||
| Q2 25 | -93.4% | 25.4% | ||
| Q1 25 | -143.7% | 13.1% | ||
| Q4 24 | -98.6% | 19.5% | ||
| Q3 24 | -132.0% | 17.3% | ||
| Q2 24 | -139.2% | 19.2% | ||
| Q1 24 | -538.7% | 14.7% |
| Q4 25 | -83.0% | — | ||
| Q3 25 | -103.1% | 21.4% | ||
| Q2 25 | -96.1% | 20.3% | ||
| Q1 25 | -151.4% | 10.2% | ||
| Q4 24 | -103.6% | — | ||
| Q3 24 | -131.2% | 13.9% | ||
| Q2 24 | -110.9% | 15.4% | ||
| Q1 24 | -544.4% | 9.4% |
| Q4 25 | $-0.73 | $0.43 | ||
| Q3 25 | $-0.82 | $0.45 | ||
| Q2 25 | $-0.75 | $0.43 | ||
| Q1 25 | $-0.81 | $0.17 | ||
| Q4 24 | $-0.71 | $0.28 | ||
| Q3 24 | $-0.73 | $0.26 | ||
| Q2 24 | $-0.55 | $0.31 | ||
| Q1 24 | $-2.35 | $0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $388.9M | — |
| Total DebtLower is stronger | — | $412.3M |
| Stockholders' EquityBook value | $139.1M | $349.4M |
| Total Assets | $480.2M | $2.3B |
| Debt / EquityLower = less leverage | — | 1.18× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $388.9M | — | ||
| Q3 25 | $416.1M | — | ||
| Q2 25 | $291.0M | — | ||
| Q1 25 | $314.5M | — | ||
| Q4 24 | $320.6M | — | ||
| Q3 24 | $298.4M | — | ||
| Q2 24 | $319.1M | — | ||
| Q1 24 | $201.2M | — |
| Q4 25 | — | $412.3M | ||
| Q3 25 | — | $469.1M | ||
| Q2 25 | — | $465.7M | ||
| Q1 25 | — | $395.9M | ||
| Q4 24 | — | $446.5M | ||
| Q3 24 | — | $560.1M | ||
| Q2 24 | — | $660.8M | ||
| Q1 24 | — | $634.2M |
| Q4 25 | $139.1M | $349.4M | ||
| Q3 25 | $148.8M | $345.5M | ||
| Q2 25 | $-11.9M | $341.5M | ||
| Q1 25 | $18.9M | $341.4M | ||
| Q4 24 | $21.7M | $339.1M | ||
| Q3 24 | $11.2M | $342.0M | ||
| Q2 24 | $39.3M | $334.9M | ||
| Q1 24 | $61.6M | $338.0M |
| Q4 25 | $480.2M | $2.3B | ||
| Q3 25 | $506.9M | $2.3B | ||
| Q2 25 | $372.7M | $2.3B | ||
| Q1 25 | $386.7M | $2.2B | ||
| Q4 24 | $392.3M | $2.2B | ||
| Q3 24 | $363.6M | $2.2B | ||
| Q2 24 | $381.8M | $2.3B | ||
| Q1 24 | $258.7M | $2.2B |
| Q4 25 | — | 1.18× | ||
| Q3 25 | — | 1.36× | ||
| Q2 25 | — | 1.36× | ||
| Q1 25 | — | 1.16× | ||
| Q4 24 | — | 1.32× | ||
| Q3 24 | — | 1.64× | ||
| Q2 24 | — | 1.97× | ||
| Q1 24 | — | 1.88× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-25.4M | $24.2M |
| Free Cash FlowOCF − Capex | — | $23.0M |
| FCF MarginFCF / Revenue | — | 61.9% |
| Capex IntensityCapex / Revenue | — | 3.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $43.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-25.4M | $24.2M | ||
| Q3 25 | $-26.6M | $32.7M | ||
| Q2 25 | $-23.3M | $-38.4M | ||
| Q1 25 | $-40.4M | $26.7M | ||
| Q4 24 | $-18.8M | $48.1M | ||
| Q3 24 | $-25.2M | $74.1M | ||
| Q2 24 | $-29.1M | $-39.5M | ||
| Q1 24 | $-40.7M | $-9.9M |
| Q4 25 | — | $23.0M | ||
| Q3 25 | — | $32.4M | ||
| Q2 25 | — | $-38.5M | ||
| Q1 25 | — | $26.5M | ||
| Q4 24 | — | $47.0M | ||
| Q3 24 | — | $73.9M | ||
| Q2 24 | — | $-39.7M | ||
| Q1 24 | — | $-10.3M |
| Q4 25 | — | 61.9% | ||
| Q3 25 | — | 87.5% | ||
| Q2 25 | — | -101.2% | ||
| Q1 25 | — | 89.2% | ||
| Q4 24 | — | 147.5% | ||
| Q3 24 | — | 216.9% | ||
| Q2 24 | — | -106.7% | ||
| Q1 24 | — | -31.9% |
| Q4 25 | — | 3.1% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.9% | ||
| Q4 24 | — | 3.5% | ||
| Q3 24 | — | 0.6% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 1.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | 4.13× | ||
| Q2 25 | — | -4.98× | ||
| Q1 25 | — | 8.81× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 15.67× | ||
| Q2 24 | — | -6.92× | ||
| Q1 24 | — | -3.27× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
